Sarepta's DMD Portfolio Solid, Sole Drug Dependence Concerns July 5, 2018 admin Trading Ideas Comments Off on Sarepta's DMD Portfolio Solid, Sole Drug Dependence Concerns Sarepta Therapeutics’ (SRPT) DMD drug sales are rising and pipeline candidates are progressing well. However, dependence on a single product for near-term growth is a concern. …read more Source:: Yahoo Finance Did you enjoy this article? Join our FREE Newsletter! I agree to have my personal information transfered to MailChimp ( more information ) Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.We hate spam. Your email address will not be sold or shared with anyone else.